Research Current Studies and Recruitment

Current Studies

Lakeside Healthcare Research and Innovation Unit

  • GSK COPD PAS – A study looking at safety cardiovascular outcome data for two inhalers used in the management of COPD – GSK is the Trial Sponsor.
  • Amgen Vesalius CV Study – A study looking at the efficacy of the drug Evolocumab (Repatha) is at lowering LDL-C in patients at risk of having a cardiovascular event – Amgen is the Trial Sponsor.
  • Novavax 2019nCoV-302 – A vaccine study looking at the efficacy of the Novavax Covid-19 vaccine in Adults in preventing serious Covid-19 Illness – Novavax is the Trial Sponso
  • Valneva VLA2001-301 – A vaccine study looking at the efficacy of the Valneva Covid-19 vaccine in Adults in preventing serious Covid-19 Illness – Valneva is the Trial Sponsor
  • GSK RSV 006 – A vaccine study looking at the efficacy of a RSV (Respiratory Syncytial Virus) vaccine within older adults living in the community in preventing RSV infection – GSK is the Trial Sponsor
  • Astrazeneca LOGOS study – An Asthma study looking at the effectiveness of new combined triple therapy inhaler in patients with inadequately controlled Asthma – Astrazeneca is the Trial sponsor
  • Boehringer Ingelheim 0022 CKD Study – A study for Chronic Kidney Disease looking at a new therapy to improve Kidney Function – Boehringer Ingelheim is the Trial Sponsor
  • GMRx2 - Clinical trial testing a new treatment for blood lowering drugs
  • Moderna CMVictory phase 3 vaccine trial. Testing a new investigational vaccine (mRNA-1647) for its safety and effectiveness in preventing CMV in healthy adult females.
  • mRNA-1769-P101 Mpox mPower Trial -  A clinical trial of an investigational mpox vaccine for adults ages 18–49.
 

Recruitment

Lakeside Research